Form 4: Oncology Institute Insider Reports Stock Transaction
Insider Transaction (Form 4)
Jorey Chernett, a 10% owner of Oncology Institute, Inc., reported multiple transactions in common stock on August 13, 2026.
Summary
- Open-market purchase: acquired 12,000 Common Stock at $6.54 ($78,480) on August 14, 2026; holds 10,660,858 after (Direct).
- Open-market sale: disposed of 100 Call Option (STLN 19FEB27 $9C) at $6.24 ($624) on August 13, 2026 (Direct).
Sentiment
Score: 6
Explanation: StockSavvy.ai notes net insider buying of $77,856 across mixed open-market transactions.
Insider Transactions
Jorey Chernett — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Common Stock | 12,000 | $7 | $78.5K | 10,660,858 |
| 2026-08-13 | Open-market sale | Call Option (STLN 19FEB27 $9C) | 100 | $6 | $624 | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (12,000 shares) |
| 2026-08-13 | Open-market sale (100 shares) |
Keywords
insider transaction, Form 4, STLN, Starling Oncology, Inc., net buying, Jorey Chernett
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.